
Ask a doctor about a prescription for APREGIA 25 mg HARD CAPSULES
Package Leaflet: Informationfortheuser
Apregia25mghardcapsulesEFG
pregabalin
Readtheentirepackageleafletcarefullybeforestartingtotakethismedication,asitcontainsimportantinformationforyou.
Contentsofthepackageleaflet
Apregia belongs to a group of medications used to treat epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Peripheral and central neuropathic pain:Pregabalin is used to treat chronic pain caused by nerve damage. There are various diseases that can cause peripheral neuropathic pain, such as diabetes or herpes. The sensation of pain can be described as heat, burning, throbbing pain, shooting pain, stabbing pain, acute pain, spasms, continuous pain, tingling, numbness, and a feeling of pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can affect physical and social activity and overall quality of life.
Epilepsy:Pregabalin is used in the treatment of certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe pregabalin to treat epilepsy when your current treatment does not control the disease. You should take pregabalin in addition to your current treatment. Pregabalin should not be taken alone, but always in combination with other antiepileptic treatments.
Generalized anxiety disorder:Pregabalin is used to treat generalized anxiety disorder (GAD). The symptoms of GAD are excessive and prolonged anxiety and worry that are difficult to control. GAD can also cause restlessness or a feeling of excitement or nervousness, feeling tired (fatigued) easily, having difficulty concentrating or keeping your mind blank, irritability, muscle tension, or sleep disturbances. This is different from the stress and tensions of everyday life.
Do not take Apregia
If you are allergic to pregabalin or any of the other components of this medication (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Apregia.
Dependence
Some people may become dependent on pregabalin (need to continue taking the medication). They may experience withdrawal effects when they stop taking pregabalin (see section 3 "How to take Apregia" and "If you stop taking Apregia"). If you are concerned that you may become dependent on pregabalin, it is important that you consult your doctor.
If you notice any of the following signs while taking pregabalin, it could be a sign that you have become dependent:
If you notice any of these signs, talk to your doctor to discuss the best care plan for you, including when it is appropriate to stop treatment and how to do it safely.
Children and adolescents
The safety and efficacy of pregabalin in children and adolescents (under 18 years of age) have not been established, so pregabalin should not be used in this age group.
Other medications and Apregia
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medications.
Pregabalin and certain medications may interact with each other (interactions). When pregabalin is used with certain medications that have a sedative effect (including opioids), these effects may be enhanced, and may lead to respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if pregabalin is taken with other medications that contain:
Pregabalin can be taken with oral contraceptives.
Taking Apregia with food, drinks, and alcohol
Pregabalin capsules can be taken with or without food.
It is advised not to drink alcohol during treatment with pregabalin.
Pregnancy and breastfeeding
You should not take pregabalin during pregnancy or breastfeeding, unless your doctor has told you to do so. The use of pregabalin during the first 3 months of pregnancy may cause congenital malformations in the fetus that require medical treatment. In a study that reviewed data from women in Nordic countries who took pregabalin in the first 3 months of pregnancy, 6 babies out of 100 had such congenital malformations. This compares to 4 babies out of 100 born to women not treated with pregabalin in the study. Malformations of the face (cleft lip and palate), eyes, nervous system (including the brain), kidneys, and genitals have been reported.
An effective contraceptive method should be used in women of childbearing age. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and using machines
Pregabalin may cause dizziness, somnolence, and decreased concentration. You should not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know if this medication affects your ability to perform these activities.
Follow the instructions for administration of this medication indicated by your doctor. If you are unsure, consult your doctor or pharmacist again. Do not take more medication than prescribed.
Your doctor will determine the appropriate dose for you.
Apregia is for oral use only.
Peripheral and central neuropathic pain, epilepsy, or generalized anxiety disorder:
If you think the effect of pregabalin is too strong or too weak, tell your doctor or pharmacist.
If you are an elderly patient (over 65 years of age), you should take pregabalin normally, except if you have kidney problems.
Your doctor may prescribe a different dosing regimen or different doses if you have kidney problems.
Swallow the capsule whole with water.
Continue taking pregabalin until your doctor tells you to stop.
If you take more Apregia than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or go to the nearest emergency department. Bring the package or bottle of Apregia capsules with you. You can also call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
As a result of taking more Apregia than you should, you may feel somnolent, confused, agitated, or restless. Seizures and loss of consciousness (coma) have also been reported.
If you forget to take Apregia
It is important that you take the pregabalin capsules regularly at the same time every day. If you forget to take a dose, take it as soon as you remember, unless it is time for the next dose. In that case, continue with the next dose as usual. Do not take a double dose to make up for forgotten doses.
If you stop taking Apregia
Do not stop taking pregabalin suddenly. If you want to stop taking pregabalin, talk to your doctor first. He will tell you how to do it. If you are going to stop treatment, it should be done gradually over a minimum of one week.
Once you have finished treatment with pregabalin for a long or short period, you should know that you may experience certain side effects, called withdrawal effects. These effects include sleep problems, headache, nausea, feeling of anxiety, diarrhea, flu-like symptoms, seizures, nervousness, depression, thoughts of self-harm or suicide, pain, sweating, and dizziness. These effects may occur more frequently or severely if you have been taking pregabalin for a longer period. If you experience withdrawal effects, you should see your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Verycommon:mayaffectmorethan1in10people
Common:mayaffectup to1in10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known: cannot be estimated from available data
Once short-term treatment with pregabalin is finished, you should know that you may experience certain adverse effects, called withdrawal effects (see "If you stop treatment with Apregia").
Ifyouexperienceswellinginthefaceoronthetongue,orifyourskinturnsredandhasblistersorpeeling,youshouldseekmedicalattentionimmediately.
Certain adverse effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medications to treat, for example, pain or spasticity (stiff or rigid muscles), with adverse effects similar to those of pregabalin, so the intensity of these effects may increase when taken together.
The following adverse reaction has been reported in post-marketing experience: difficulty breathing, shallow breathing.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es/. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Apregia
The active ingredient is pregabalin. Each hard capsule contains 25 mg of pregabalin.
The other components are: pregelatinized starch (from corn), talc (E553b), titanium dioxide (E171), gelatin (E441), black printing ink - shellac (E904), iron oxide black (E172), and propylene glycol (E1520).
Appearance of the product and package contents
Hard capsules with a white body and cap. The cap of the capsule has the black mark "P25" printed on it. The contents of the capsule are a white or almost white powder. The length of the capsule is 13.8-14.8 mm.
Apregia is presented in blister packs containing 56 hard capsules.
Marketing authorization holder and manufacturer
Marketing authorization holder
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
Date of the last revision of this prospectus:January 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of APREGIA 25 mg HARD CAPSULES in November, 2025 is around 4.9 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for APREGIA 25 mg HARD CAPSULES – subject to medical assessment and local rules.